← Companies|Dyno Ther
Dy

Dyno Ther

Watertown MAFounded 201870 employees
Private CapbiotechPrivateGenetic Medicine
Platform: AAV Capsid AI
Market Cap
N/A
All Drugs
2
Clinical Trials
5
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
RilufutibatinibDYN-1228Phase 33DegraderGPRC5DSTINGagCRCNarcolepsy
DYN-1761DYN-1761Phase 12Bispecific AbCDK4/6MeniniLN
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)
2026-10-01
DYN-1761 Interim
LN
Interim
2028-09-22
Rilufutibatinib Ph3 Readout
Narcolepsy
Ph3 Readout
2029-02-11
Rilufutibatinib Ph3 Readout
CRC
Ph3 Readout
2031-02-09
Rilufutibatinib Ph3 Readout
CRC
Ph3 Readout